TIDMIMM

RNS Number : 1863A

Immupharma PLC

22 March 2017

 
   22 MARCH 2017 
 

NOTIFICATION OF MAJOR INTEREST BY ALTO INVEST

ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Alto Invest ("Alto") confirming its holding in ImmuPharma of 5,802,317 million Ordinary Shares in the capital of the Company, representing 4.38% of ImmuPharma's total voting rights figure of 132,522,985 Ordinary Shares.

Commenting, Tim McCarthy, Chairman of ImmuPharma, said: "We are delighted to be able to disclose Alto's increased holding in ImmuPharma as a further key major institutional investor which participated in our recent successful GBP4.1 million fundraising demonstrating its continued support for ImmuPharma."

Ends

 
 For further information please 
  contact: 
                                           + 44 (0) 20 
   ImmuPharma plc (www.immupharma.org)       7152 4080 
   Tim McCarthy, Chairman 
   Lisa Baderoon, Head of Investor 
    Relations                             + 44 (0) 7721 
    Twitter: @immupharma                      413496 
   Northland Capital Partners Limited 
    (NOMAD & Broker) 
    Patrick Claridge, David Hignell, 
    Michael Mackintosh, Corporate 
    Finance                               +44 (0)20 3861 
    Rob Rees, Corporate Broking                6625 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLVLLBLDXFZBBK

(END) Dow Jones Newswires

March 22, 2017 04:51 ET (08:51 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Immupharma Charts.
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Immupharma Charts.